Liu Q
Clin Exp Med. 2025; 25(1):77.
PMID: 40063304
PMC: 11893680.
DOI: 10.1007/s10238-025-01618-x.
Manska S, Hagemann A, Magana J, Rossetto C, Verma S
Viruses. 2025; 17(2).
PMID: 40006904
PMC: 11860937.
DOI: 10.3390/v17020149.
Koh H, Han N, Hyun C
Medicine (Baltimore). 2025; 104(8):e41668.
PMID: 39993107
PMC: 11856967.
DOI: 10.1097/MD.0000000000041668.
Heidari R, Assadollahi V, Marashi S, Elahian F, Mirzaei S
Biomed Res Int. 2025; 2025:5538575.
PMID: 39949372
PMC: 11824705.
DOI: 10.1155/bmri/5538575.
Tsamouri M, Kent M, Mudryj M, Ghosh P
Vet Oncol. 2025; 1.
PMID: 39944718
PMC: 11815638.
DOI: 10.1186/s44356-024-00011-2.
Long non-coding RNA involved in the carcinogenesis of human female cancer - a comprehensive review.
Afroze N, Sundaram M, Haque S, Hussain A
Discov Oncol. 2025; 16(1):122.
PMID: 39912983
PMC: 11803034.
DOI: 10.1007/s12672-025-01848-1.
Comprehensive insights and In silico analysis into the emerging role of LincRNAs in lung diseases pathogenesis; a step toward ncRNA precision.
Hamdy N, Zaki M, Abdelmaksoud N, Elshaer S, Abd-Elmawla M, Rizk N
Funct Integr Genomics. 2025; 25(1):34.
PMID: 39912974
PMC: 11802690.
DOI: 10.1007/s10142-025-01540-1.
Discovering novel prognostic biomarkers of hepatocellular carcinoma using eXplainable Artificial Intelligence.
Gutierrez-Chakraborty E, Chakraborty D, Das D, Bai Y
Expert Syst Appl. 2025; 252(Pt B.
PMID: 39829683
PMC: 11737334.
DOI: 10.1016/j.eswa.2024.124239.
RNA splicing variants of the novel long non-coding RNA, CyKILR, possess divergent biological functions in non-small cell lung cancer.
Xie X, Macknight H, Lu A, Chalfant C
Mol Ther Nucleic Acids. 2025; 36(1):102412.
PMID: 39807365
PMC: 11728077.
DOI: 10.1016/j.omtn.2024.102412.
Non-Coding RNAs in Breast Cancer: Diagnostic and Therapeutic Implications.
Benacka R, Szaboova D, Gulasova Z, Hertelyova Z
Int J Mol Sci. 2025; 26(1.
PMID: 39795985
PMC: 11719911.
DOI: 10.3390/ijms26010127.
Dysregulated LINC01133 expression in laryngeal carcinoma: Prognostic implications and predicted ceRNA interactome.
Razipour M, Jamali Z, Sohrabpour S, Heidari F, Lotfi M, Ghadami E
Mol Biol Res Commun. 2025; 14(1):93-107.
PMID: 39744510
PMC: 11624609.
DOI: 10.22099/mbrc.2024.50390.1996.
High Expression of MRPL23 Is Associated with Poor Survival in Clear-Cell Renal Cell Carcinoma.
Podemska E, Borowczak J, Lukasik D, Grzanka D, Durslewicz J
Cancers (Basel). 2024; 16(23).
PMID: 39682098
PMC: 11640366.
DOI: 10.3390/cancers16233909.
The oncogenic lncRNA MIR503HG suppresses cellular senescence counteracting supraphysiological androgen treatment in prostate cancer.
Kallenbach J, Rasa M, Heidari Horestani M, Atri Roozbahani G, Schindler K, Baniahmad A
J Exp Clin Cancer Res. 2024; 43(1):321.
PMID: 39676172
PMC: 11648305.
DOI: 10.1186/s13046-024-03233-2.
GAS5 long non-coding RNA interacts with microRNA-205 to relieve fibroblast-like synoviocyte inflammation and ferroptosis in osteoarthritis.
Gu Y, Wang G, Chen P
Apoptosis. 2024; 30(1-2):320-333.
PMID: 39644356
DOI: 10.1007/s10495-024-02051-3.
Expression pattern of long non-coding RNAs in treatment-naïve and medicated schizophrenia patients.
Javidi Aghdam K, Baradaran B, Rahmani S, Manafzadeh F, Noor Azar S, Aghayan S
Sci Rep. 2024; 14(1):27654.
PMID: 39532914
PMC: 11557838.
DOI: 10.1038/s41598-024-78220-w.
lncRNAs'p potential roles in the pathogenesis of cancer via interacting with signaling pathways; special focus on lncRNA-mediated signaling dysregulation in lung cancer.
Shelash S, Shabeeb I, Ahmad I, Saleem H, Bansal P, Kumar A
Med Oncol. 2024; 41(12):310.
PMID: 39516331
DOI: 10.1007/s12032-024-02536-w.
Exploring the clinical potential of circulating LncRNAs in breast cancer: insights into primary signaling pathways and therapeutic interventions.
Al-Noshokaty T, Abdelhamid R, Reda T, Alaaeldien A, Abdellatif N, Mansour A
Funct Integr Genomics. 2024; 24(6):209.
PMID: 39508907
DOI: 10.1007/s10142-024-01476-y.
Serum HOTTIP expression is upregulated in nasopharyngeal carcinoma patients and predicts poor prognosis.
Wang D, Luo J, Feng H, Wang Y
Braz J Otorhinolaryngol. 2024; 91(1):101471.
PMID: 39500018
PMC: 11580017.
DOI: 10.1016/j.bjorl.2024.101471.
The clinical potential of l-oligonucleotides: challenges and opportunities.
Shearer V, Yu C, Han X, Sczepanski J
Chem Sci. 2024; .
PMID: 39479156
PMC: 11514577.
DOI: 10.1039/d4sc05157b.
Recent Advances and Prospects of Nucleic Acid Therapeutics for Anti-Cancer Therapy.
Lee M, Lee M, Song Y, Kim S, Park N
Molecules. 2024; 29(19).
PMID: 39407665
PMC: 11477775.
DOI: 10.3390/molecules29194737.